SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2649
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures ; volume:18 ; number:9 ; day:28 ; month:8 ; year:2009 ; pages:1219-1237 ; date:11.2009
Quality of life research ; 18, Heft 9 (28.8.2009), 1219-1237, 11.2009
- Creator
-
Brown, Carlos A.
Cheng, Eric M.
Hays, Ron D.
Vassar, Stefanie D.
Vickrey, Barbara G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11136-009-9530-y
- URN
-
urn:nbn:de:101:1-2023051122123600892337
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brown, Carlos A.
- Cheng, Eric M.
- Hays, Ron D.
- Vassar, Stefanie D.
- Vickrey, Barbara G.
- SpringerLink (Online service)
Other Objects (12)
GBA-associated PD: chances and obstacles for targeted treatment strategies
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
PD-Nachrichten: "PD-Info"
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
PD
PD
PD
Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
GBA-associated PD: chances and obstacles for targeted treatment strategies
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
PD-Nachrichten: "PD-Info"
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
PD
PD
PD
Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
GBA-associated PD: chances and obstacles for targeted treatment strategies
Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma
PD-Nachrichten: "PD-Info"
Targeted delivery of Fc-fused PD-L1 for effective management of acute and chronic colitis
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
PD
PD
PD
Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging